High anaphylaxis rates following vaccination with the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: a secondary analysis of initial post-approval safety data
Takanao Hashimoto, Akihiko Ozaki, Divya Bhandari, Toyoaki Sawano, Ranjit Sah, Tetsuya Tanimoto
Topics & Concepts
MedicineVaccinationCoronavirus disease 2019 (COVID-19)Anaphylaxis2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Health careHealthcare workerVirologyImmunologyAllergyInternal medicineOutbreakDiseaseEconomic growthEconomicsInfectious disease (medical specialty)Food Allergy and Anaphylaxis ResearchSARS-CoV-2 and COVID-19 ResearchInfection Control and Ventilation